Comparative Effectiveness and Safety of Nifedipine and Magnesium Sulfate As Treatment Options for Preterm Birth: a Systematic Review and Meta-analysis

Overview

Journal BMJ Open

Specialty General Medicine

Date 2025 Feb 22

PMID 39987000

Authors

Jianing Fan

Qianqian Lu

Jie Chen

Pingping Lin

Chong Fan

Juan Lyv

Yuhan Zhang

Xinyan Wang

Affiliations

Soon will be listed here.

Abstract

Objectives: Preterm birth (PTB) is a major cause of neonatal morbidity and mortality worldwide. Effective use of tocolytic agents may improve perinatal outcomes. This study aims to compare the effectiveness and safety of nifedipine and magnesium sulfate in the treatment of PTB.

Design: A systematic review and meta-analysis.

Data Sources: China National Knowledge Infrastructure, China Science and Technology Journal Database, WanFang, PubMed, Embase, Web of Science and Cochrane were searched from inception to 1 December 2024.

Eligibility Criteria: We included randomised controlled trials (RCTs) and cohort studies that compare the efficacy and safety of magnesium sulfate versus nifedipine in treating PTB.

Data Extraction And Synthesis: Two researchers independently screened studies and extracted data. Risk of bias was assessed using the Cochrane risk-of-bias assessment tool for RCTs and the modified Newcastle-Ottawa Scale for non-randomised studies. Meta-analysis was conducted using Review Manager V.5.4.

Results: In all, 50 articles were included in this review, comprising 6072 cases (n=3014 for the magnesium sulfate group; n=3058 for the nifedipine group). Compared with the magnesium sulfate group, the nifedipine group was more favourable in terms of time to onset of action and prolongation of days of gestation, as well as higher neonatal 1 min Apgar scores. The use of magnesium sulfate was associated with a higher incidence of maternal side effects, specifically tachycardia, flushing, palpitations, dizziness and nausea. In addition, the magnesium sulfate group also showed a higher incidence of neonatal respiratory distress syndrome than the nifedipine group.

Conclusion: Compared with magnesium sulfate, nifedipine is more effective with a faster onset of action and a longer prolonging pregnancy. Additionally, nifedipine may be safer for fewer maternal side effects and better neonatal outcomes. Further studies are needed to confirm the long-term safety and efficacy of these treatments.

References

Lyell D, Pullen K, Campbell L, Ching S, Druzin M, Chitkara U . Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial. Obstet Gynecol. 2007; 110(1):61-7. DOI: 10.1097/01.AOG.0000269048.06634.35. View

Han S, Crowther C, Moore V . Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. Cochrane Database Syst Rev. 2010; (7):CD000940. DOI: 10.1002/14651858.CD000940.pub2. View

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

Wilson A, Hodgetts-Morton V, Marson E, Markland A, Larkai E, Papadopoulou A . Tocolytics for delaying preterm birth: a network meta-analysis (0924). Cochrane Database Syst Rev. 2022; 8:CD014978. PMC: 9364967. DOI: 10.1002/14651858.CD014978.pub2. View

Vaast P, Dubreucq-Fossaert S, Houfflin-Debarge V, Provost-Helou N, Ducloy-Bouthors A, Puech F . Acute pulmonary oedema during nicardipine therapy for premature labour; Report of five cases. Eur J Obstet Gynecol Reprod Biol. 2004; 113(1):98-9. DOI: 10.1016/j.ejogrb.2003.05.004. View

Larmon J, Ross B, May W, Dickerson G, Fischer R, Morrison J . Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor. Am J Obstet Gynecol. 1999; 181(6):1432-7. DOI: 10.1016/s0002-9378(99)70388-1. View

Stroup D, Berlin J, Morton S, Olkin I, Williamson G, Rennie D . Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283(15):2008-12. DOI: 10.1001/jama.283.15.2008. View

Crocker T, Lam N, Jordao M, Brundle C, Prescott M, Forster A . Risk-of-bias assessment using Cochrane's revised tool for randomized trials (RoB 2) was useful but challenging and resource-intensive: observations from a systematic review. J Clin Epidemiol. 2023; 161:39-45. DOI: 10.1016/j.jclinepi.2023.06.015. View

Walker K, Thornton J . Tocolysis and preterm labour. Lancet. 2016; 387(10033):2068-2070. DOI: 10.1016/S0140-6736(16)00590-0. View

10.

Greenberg M, Penn A, Thomas L, El-Sayed Y, Caughey A, Lyell D . Neonatal medical admission in a term and late-preterm cohort exposed to magnesium sulfate. Am J Obstet Gynecol. 2011; 204(6):515.e1-7. DOI: 10.1016/j.ajog.2011.01.046. View

11.

Magee L, De Silva D, Sawchuck D, Synnes A, von Dadelszen P . No. 376-Magnesium Sulphate for Fetal Neuroprotection. J Obstet Gynaecol Can. 2019; 41(4):505-522. DOI: 10.1016/j.jogc.2018.09.018. View

12.

Nikbakht R, Taheri Moghadam M, Ghaneee H . Nifedipine compared to magnesium sulfate for treating preterm labor: A randomized clinical trial. Iran J Reprod Med. 2014; 12(2):145-50. PMC: 4009567. View

13.

Morgan M, Goldenberg R, Schulkin J . Obstetrician-gynecologists' screening and management of preterm birth. Obstet Gynecol. 2008; 112(1):35-41. DOI: 10.1097/AOG.0b013e31817c50fc. View

14.

Shepherd E, Salam R, Manhas D, Synnes A, Middleton P, Makrides M . Antenatal magnesium sulphate and adverse neonatal outcomes: A systematic review and meta-analysis. PLoS Med. 2019; 16(12):e1002988. PMC: 6897495. DOI: 10.1371/journal.pmed.1002988. View

15.

Brookfield K, Su F, Elkomy M, Drover D, Lyell D, Carvalho B . Pharmacokinetics and placental transfer of magnesium sulfate in pregnant women. Am J Obstet Gynecol. 2016; 214(6):737.e1-9. DOI: 10.1016/j.ajog.2015.12.060. View

16.

Haghighi L . Prevention of preterm delivery: nifedipine or magnesium sulfate. Int J Gynaecol Obstet. 1999; 66(3):297-8. DOI: 10.1016/s0020-7292(99)00095-8. View

17.

Klauser C, Briery C, Martin R, Langston L, Magann E, Morrison J . A comparison of three tocolytics for preterm labor: a randomized clinical trial. J Matern Fetal Neonatal Med. 2013; 27(8):801-6. DOI: 10.3109/14767058.2013.847416. View

18.

Crowther C, Brown J, McKinlay C, Middleton P . Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev. 2014; (8):CD001060. PMC: 10838393. DOI: 10.1002/14651858.CD001060.pub2. View

19.

Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong K . Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet Child Adolesc Health. 2021; 6(2):106-115. PMC: 8786667. DOI: 10.1016/S2352-4642(21)00311-4. View

20.

Ohuma E, Moller A, Bradley E, Chakwera S, Hussain-Alkhateeb L, Lewin A . National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis. Lancet. 2023; 402(10409):1261-1271. DOI: 10.1016/S0140-6736(23)00878-4. View